Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP178883.RAd59WWOJJyk9WgGyNqnb-F4Y9-G2ih4hGFQRFv38BViM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP178883.RAd59WWOJJyk9WgGyNqnb-F4Y9-G2ih4hGFQRFv38BViM130_assertion type Assertion NP178883.RAd59WWOJJyk9WgGyNqnb-F4Y9-G2ih4hGFQRFv38BViM130_head.
- NP178883.RAd59WWOJJyk9WgGyNqnb-F4Y9-G2ih4hGFQRFv38BViM130_assertion description "[MM shows frequent genetic inactivation of tumor suppressor genes of p16(INK4a)/p14(ARF) and neurofibromatosis type 2 (NF2) which encodes Merlin, and epigenetic inactivation of RASSF1A.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP178883.RAd59WWOJJyk9WgGyNqnb-F4Y9-G2ih4hGFQRFv38BViM130_provenance.
- NP178883.RAd59WWOJJyk9WgGyNqnb-F4Y9-G2ih4hGFQRFv38BViM130_assertion evidence source_evidence_literature NP178883.RAd59WWOJJyk9WgGyNqnb-F4Y9-G2ih4hGFQRFv38BViM130_provenance.
- NP178883.RAd59WWOJJyk9WgGyNqnb-F4Y9-G2ih4hGFQRFv38BViM130_assertion SIO_000772 19793348 NP178883.RAd59WWOJJyk9WgGyNqnb-F4Y9-G2ih4hGFQRFv38BViM130_provenance.
- NP178883.RAd59WWOJJyk9WgGyNqnb-F4Y9-G2ih4hGFQRFv38BViM130_assertion wasDerivedFrom befree-20140225 NP178883.RAd59WWOJJyk9WgGyNqnb-F4Y9-G2ih4hGFQRFv38BViM130_provenance.
- NP178883.RAd59WWOJJyk9WgGyNqnb-F4Y9-G2ih4hGFQRFv38BViM130_assertion wasGeneratedBy ECO_0000203 NP178883.RAd59WWOJJyk9WgGyNqnb-F4Y9-G2ih4hGFQRFv38BViM130_provenance.